Alex Buko

2.8k citations

29 papers · 2.0k indexed · 1 hit paper · h-index 18

Impact in

Virology top 5%
- HIV Research and Treatment
Biological Psychiatry top 10%

Papers in ⓘ

Molecular Biology 9
Pharmacology 8
- Microbial Natural Products and Biosynthesis 8

Co-authors: Jon F. Denissen (2 shared papers)A. David Rodrigues (1 shared paper)Gondi Kumar (1 shared paper)Susan Goelz (2 shared papers)Rebecca Conrad (1 shared paper)Gisa Ellrichmann (1 shared paper)Ralf A. Linker (1 shared paper)Pradeep Bista (1 shared paper)
Journals: The Journal of Antibiotics (8 papers)Archives of Biochemistry and Biophysics (2 papers)Redox Biology (2 papers)Proceedings of the National Academy of Sciences (2 papers)SLAS DISCOVERY (1 paper)
Partner nations: United States United Kingdom Germany

In The Last Decade

Alex Buko

29 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway 2011 · 892 citations

Peers

Countries citing papers authored by Alex Buko

Since Specialization

Citations

This map shows the geographic impact of Alex Buko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Buko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Buko more than expected).

Fields of papers citing papers by Alex Buko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Buko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Buko. The network helps show where Alex Buko may publish in the future.

Co-authors

The 25 scholars most cited alongside Alex Buko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alex Buko Line = papers co-authored together Alex Buko links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway Brain ·Ralf A. Linker, De-Hyung Lee, Sarah Ryan, Anne Marie Van Dam, Rebecca Conrad, Pradeep Bista, Weike Zeng, Xiaoping Hronowsky, Alex Buko, Sowmya Chollate, Gisa Ellrichmann, Wolfgang Brück, K. P. DAWSON, Susan Goelz, Stefan Wiese, Robert H. Scannevin, Matvey Lukashev, Ralf Gold Hit paper breakdown →	2011	892
2	Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes. Journal of Pharmacology and Experimental Therapeutics ·Gondi Kumar, A. David Rodrigues, Alex Buko, Jon F. Denissen	1996	299
3	Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans. PubMed ·Jon F. Denissen, Brian Grabowski, Marianne K. Johnson, Alex Buko, Dale J. Kempf, Samuel Thomas, Bruce W. Surber	1997	115
4	Ethyl-substituted erythromycin derivatives produced by directed metabolic engineering Proceedings of the National Academy of Sciences ·Diane L. Stassi, Stephan J. Kakavas, Kevin A. Reynolds, Geewananda P. Gunawardana, Sue Swanson, D. Zeidner, MARIANNA JACKSON, H. Liu, Alex Buko, Leonard Katz	1998	102
5	Tiacumicins, a novel complex of 18-membered macrolides. II. Isolation and structure determination. The Journal of Antibiotics ·Jill E. Hochlowski, Sue Swanson, L. M. RANFRANZ, David N. Whittern, Alex Buko, James B. McAlpine	1987	72
6	Characterization of a posttranslational fucosylation in the growth factor domain of urinary plasminogen activator. Proceedings of the National Academy of Sciences ·Alex Buko, Elzbieta J. Kentzer, Andrew M. Petros, Gowtham Menon, Erik R. P. Zuiderweg, Virender K. Sarin	1991	50
7	Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS Neurology ·Steven E Bushnell, Zhao Zhi-gang, Christopher Stebbins, Diego Cadavid, Alex Buko, Eric T. Whalley, John A. Davis, Eve Versage, J Richert, Robert C. Axtell, Lawrence Steinman, R. Medori	2012	48
8	Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus Biochemical Journal ·John F. Bohnsack, Karl W. Mollison, Alex Buko, James Ashworth, Harry R. Hill	1991	46
9	New antibiotics from genetically engineered actinomycetes. I. 2-norerythromycins, isolation and structural determinations. The Journal of Antibiotics ·James B. McAlpine, J S Tuan, DAVID P. BROWN, KEVIN D. GREENER, DAVID N. WHITTERN, Alex Buko, Leonard Katz	1987	44
10	Characterization of Protein-Hapten Conjugates. 1. Matrix-Assisted Laser Desorption Ionization Mass Spectrometry of Immuno BSA-Hapten Conjugates and Comparison with Other Characterization Methods Bioconjugate Chemistry ·Maciej Adamczyk, Alex Buko, Yon-Yih Chen, Jeffrey R. Fishpaugh, John C. Gebler, Donald D. Johnson	1994	40
11	Altromycins, novel pluramycin-like antibiotics. II. Isolation and elucidation of structure. The Journal of Antibiotics ·GREGORY M. BRILL, James B. McAlpine, David N. Whittern, Alex Buko	1990	28
12	Inhibition of p56lckTyrosine Kinase by Isothiazolones Archives of Biochemistry and Biophysics ·James M. Trevillyan, X. Grace Chiou, Stephen J. Ballaron, Qing M Tang, Alex Buko, Michael P. Sheets, Morey L. Smith, C. Brent Putman, Paul E. Wiedeman, Noah P. Tu, David J. Madar, Harriet T. Smith, Earl J. Gubbins, Usha Warrior, Yung‐Wu Chen, Karl W. Mollison, Connie R. Faltynek, Stevan W. Djurić	1999	28
13	Domain analysis of urokinase plasminogen activator (u-PA): Preparation and characterization of intact A-chain molecules Fibrinolysis and Proteolysis ·Andrew P. Mazar, Alex Buko, Andrew M. Petros, Elliot S. Barnathan, Jack Henkin	1992	27
14	Coloradocin, an antibiotic from a new Actinoplanes. II. Identity with luminamicin and elucidation of structure. The Journal of Antibiotics ·Ronald R. Rasmussen, MICHAEL H. SCHERR, David N. Whittern, Alex Buko, James B. McAlpine	1987	23
15	Phenelfamycins, a novel complex of elfamycin-type antibiotics. II. Isolation and structure determination. The Journal of Antibiotics ·Jill E. Hochlowski, M. H. BUYTENDORP, David N. Whittern, Alex Buko, R. H. CHEN, J. B. MCALPINE	1988	23
16	Dunaimycins, a new complex of spiroketal 24-membered macrolides with immunosuppressive activity. II. Isolation and elucidation of structures. The Journal of Antibiotics ·Jill E. Hochlowski, MARK M. MULLALLY, GREGORY M. BRILL, David N. Whittern, Alex Buko, PRESTON HILL, James B. McAlpine	1991	21
17	JC Polyomavirus Abundance and Distribution in Progressive Multifocal Leukoencephalopathy (PML) Brain Tissue Implicates Myelin Sheath in Intracerebral Dissemination of Infection PLoS ONE ·Keith A. Wharton, Catherine Quigley, Marian Themeles, Robert W. Dunstan, Kathryn Doyle, Ellen Cahir-McFarland, Jing Wei, Alex Buko, Carl E. Reid, Chao Sun, Paul Carmillo, Gargi Sur, John P. Carulli, Keith G. Mansfield, Susan V. Westmoreland, Susan M. Staugaitis, Robert J. Fox, Werner Meier, Susan Goelz	2016	18
18	Inhibition of 3C Protease from Human Rhinovirus Strain 1B by Peptidyl Bromomethylketonehydrazides Archives of Biochemistry and Biophysics ·Warren M. Kati, Hing L. Sham, Jennifer McCall, Debra Montgomery, Gary T. Wang, William Rosenbrook, Laura R. Miesbauer, Alex Buko, Daniel W. Norbeck	1999	17
19	Fusacandins A and B; Novel Antifungal Antibiotics of the Papulacandin Class from Fusarium sambucinum. II. Isolation and Structural Elucidation. The Journal of Antibiotics ·JILL E. HOCHLOWSKI, DAVID N. WHITTERN, Alex Buko, LISA A. ALDER, James B. McAlpine	1995	16
20	Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain Molecular Psychiatry ·Orr Shahar, Alexander Botvinnik, Amit Shwartz, Elad Lerer, Peretz Golding, Alex Buko, Ethan Hamid, Dani Kahn, Miles Guralnick, Karin Blakolmer, Gilly Wolf, Amit Lotan, Leonard Lerer, Bernard Lerer, Tzuri Lifschytz	2024	15

About Alex Buko

Alex Buko is a scholar working on Molecular Biology, Pharmacology, Cancer Research, Organic Chemistry and Oncology, having authored 29 papers that have together received 2.0k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (8 papers), Synthesis and Biological Activity (4 papers), Carbohydrate Chemistry and Synthesis (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Analytical Chemistry and Chromatography (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Enzyme Production and Characterization (2 papers). The work is most often cited by research in Virology (170 citations), Biological Psychiatry (62 citations), Neurology (182 citations), Pharmacology (168 citations) and Pathology and Forensic Medicine (337 citations). Alex Buko has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Jon F. Denissen, A. David Rodrigues, Gondi Kumar, Susan Goelz, Rebecca Conrad, Gisa Ellrichmann, Ralf A. Linker, Pradeep Bista, Robert H. Scannevin and Stefan Wiese. Their work appears in journals such as The Journal of Antibiotics, Archives of Biochemistry and Biophysics, Redox Biology, Proceedings of the National Academy of Sciences and SLAS DISCOVERY.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact